Search for Clinical Trial Results

Sponsored By

Leukemia, Megakaryoblastic, Acute - 25 Studies Found

Status Study
Completed Study Name: Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
Condition:
  • Childhood Acute Megakaryocytic Leukemia (M7)
  • Childhood Acute My
    Date: 2012-07-15
    Interventions: Other: laboratory biomarker analysis Correlative studies
Recruiting Study Name: Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia
Condition:
  • Acute Megakaryoblastic Leukemia
  • Myelofibrosis
  • Drug: Alisertib Given PO
Completed Study Name: Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia
Condition: Leukemia
Date: 2010-06-05
Interventions:
  • Other: cell culture procedure
  • Other: labor
Withdrawn Study Name: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia
Condition:
  • Leukemia, Myeloid, Acute
  • Leukemia, Monocytic, Acute
  • Leukem
    Date: 2015-07-06
    Interventions:
    • Drug: Volasertib Addition of s
Recruiting Study Name: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Monoblas
    Date: 2013-02-26
    Interventions:
    • Drug: mitoxantrone hydrochloride

Active, not recruiting Study Name: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Condition:
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • Adult Acute Minimall
    Date: 2011-03-01
    Interventions:
    • Drug: caspofungin acetate Give
Completed Study Name: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2011-08-31
    Interventions:
    • Drug: cyclophosphamide Given I
Completed Study Name: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2010-08-05
    Interventions:
    • Drug: busulfan Given orally
Completed Study Name: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Condition:
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • Adult
    Date: 2010-03-24
    Interventions:
    • Procedure: double-unit umbilical cord blood transplantation

Terminated Study Name: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition:
  • Adult Acute Basophilic Leukemia
  • Adult Acute Eosinophilic Leukemia
  • Drug: idarubicin Given IV
Next >>>